{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:33:03Z","timestamp":1773149583179,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1378\/chest.127.3.922","type":"journal-article","created":{"date-parts":[[2005,3,12]],"date-time":"2005-03-12T01:58:48Z","timestamp":1110592728000},"page":"922-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["A Feasibility Study of Continuing Dose-Reduced Warfarin for Invasive Procedures in Patients With High Thromboembolic Risk"],"prefix":"10.1016","volume":"127","author":[{"given":"Bradley J. G","family":"Larson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc S","family":"Zumberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig S","family":"Kitchens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.127.3.922_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.127.3.922_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.116.5.1240","article-title":"Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery","volume":"116","author":"Douketis","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.922_bib3","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1378\/chest.119.1_suppl.22S","article-title":"Managing oral anticoagulant therapy","volume":"119","author":"Ansell","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.127.3.922_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","article-title":"Perioperative management of patients receiving oral anticoagulants","volume":"163","author":"Dunn","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.127.3.922_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-127-6-199709150-00004","article-title":"Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study","volume":"127","author":"Robinson","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.3.922_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(76)90536-5","article-title":"Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur","volume":"2","author":"Morris","year":"1976","journal-title":"Lancet"},{"key":"10.1378\/chest.127.3.922_bib7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM197106102842303","article-title":"Reduction in venous thromboembolism by agents affecting platelet function","volume":"284","author":"Salzman","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.127.3.922_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.1983.03330270038029","article-title":"Two-step warfarin therapy","volume":"249","author":"Francis","year":"1983","journal-title":"JAMA"},{"key":"10.1378\/chest.127.3.922_bib9","doi-asserted-by":"crossref","unstructured":"Stein PD, Alpert JS, Copeland J, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992; 102(suppl):445S\u2013455S","DOI":"10.1378\/chest.102.4_Supplement.445S"},{"key":"10.1378\/chest.127.3.922_bib10","unstructured":"Verstraete M, Wessler S. Heparins and oral anticoagulants. In: Fuster V, Verstraete M, eds. Thrombosis in cardiovascular disorders. Philadelphia, PA: WB Saunders, 1992; 121\u2013139"},{"key":"10.1378\/chest.127.3.922_bib11","doi-asserted-by":"crossref","unstructured":"Caprini JA, Arcelus JI, Hasty JH, et al. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991; 17(suppl):304\u2013312","DOI":"10.1055\/s-2007-1002635"},{"key":"10.1378\/chest.127.3.922_bib12","unstructured":"Gross RJ, Babbott SF. Evaluation of healthy patients and ambulatory surgical patients. In: Gross RJ, Caputo GM, eds. Kammerer and Gross' medical consultation. Baltimore, MD: Williams & Wilkins, 1998; 25\u201353"},{"key":"10.1378\/chest.127.3.922_bib13","doi-asserted-by":"crossref","unstructured":"Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38(suppl):12\u201319","DOI":"10.1016\/S0037-1963(01)90094-0"},{"key":"10.1378\/chest.127.3.922_bib14","first-page":"316a","article-title":"Validation of a venous thrombosis risk score for medical inpatients [abstract]","volume":"102","author":"Zakai","year":"2003","journal-title":"Blood"},{"key":"10.1378\/chest.127.3.922_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","article-title":"Warfarin withdrawal: Pharmacokinetic-pharmacodynamic considerations","volume":"30","author":"Palareti","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.127.3.922_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2141.1996.d01-1499.x","article-title":"Rebound after cessation of oral anticoagulant therapy: the biochemical evidence","volume":"92","author":"Genewein","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.127.3.922_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-126-2-199701150-00006","article-title":"Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy","volume":"126","author":"Harrison","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.3.922_bib18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/s-0038-1657628","article-title":"Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment","volume":"78","author":"Sallah","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.127.3.922_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1054\/arth.2002.34816","article-title":"Fatal warfarin-induced skin necrosis after total hip arthroplasty","volume":"17","author":"Clark","year":"2002","journal-title":"J Arthroplasty"},{"key":"10.1378\/chest.127.3.922_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2106\/00004623-199173010-00017","article-title":"Coumadin-induced necrosis of the skin after total knee replacement","volume":"73","author":"Bal","year":"1991","journal-title":"J Bone Joint Surg Am"},{"key":"10.1378\/chest.127.3.922_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/bmj.305.6859.913","article-title":"Low molecular weight heparin in prevention of perioperative thrombosis","volume":"305","author":"Leizorovicz","year":"1992","journal-title":"BMJ"},{"key":"10.1378\/chest.127.3.922_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9149(99)00341-0","article-title":"Use of enoxaprin for the chronically anticoagulated patient before and after procedures","volume":"84","author":"Spandorfer","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.127.3.922_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1345\/aph.10305","article-title":"Dalteparin as periprocedure anticoagulation for patients of warfarin and at high risk of thrombosis","volume":"35","author":"Tinmouth","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1378\/chest.127.3.922_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0038-1650352","article-title":"Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement","volume":"75","author":"Francis","year":"1996","journal-title":"Thromb Haemost"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215311041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:42:33Z","timestamp":1757918553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215311041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0012369215311041"],"URL":"https:\/\/doi.org\/10.1378\/chest.127.3.922","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Feasibility Study of Continuing Dose-Reduced Warfarin for Invasive Procedures in Patients With High Thromboembolic Risk","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.127.3.922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}